Concepedia

Filippo Spriano

FS

25

Publications

793

Citations

17

H-Index

2016

Active since

Affiliations

Institute of Oncology Research(Current)

Università della Svizzera italiana

SIB Swiss Institute of Bioinformatics

Mario Negri Institute for Pharmacological Research

University of Turin

Filippo Spriano is an author at Institute of Oncology Research specializing in medicine, oncology, and pharmacology.

ORCID

Top concepts

Publications per year

2016–2024

25

Publications

25

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy

Chiara Tarantelli, Eugenio Gaudio, Alberto J. Arribas et al. · Clinical Cancer Research · 2017 · 117 citations

Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

Filippo Spriano, Eugenio Gaudio, Luciano Cascione et al. · Blood Advances · 2020 · 70 citations · Full text

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Filippo Spriano, Elaine Y. Chung, Eugenio Gaudio et al. · Clinical Cancer Research · 2019 · 67 citations

The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models

Stuart W. Hicks, Chiara Tarantelli, Alan Wilhem et al. · Haematologica · 2019 · 43 citations · Full text

Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer

Tiziano Bernasocchi, Geniver El Tekle, Marco Bolis et al. · Nature Communications · 2021 · 42 citations · Full text

Rows per page

1–5 of 25